February 27, 2026 · Form 4 insider transaction
JENKINS GEORGE M bought 4,000 shares of Palvella Therapeutics at $125.00 per share, a transaction worth $500.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026.